Daptomycin With Cas 103060-53-3 99% Purity
Datomicin is a new structured cyclic lipopeptide antibiotic extracted from the fermentation broth of Streptomyces. In addition to acting on most clinically relevant gram-positive bacteria, it is more important that it has strong activity in vitro against isolated strains that have shown resistance to methicillin, vancomycin and linezolidine, This characteristic has very important clinical significance for critically infected patients.
|
Product Name: |
Daptomycin |
Batch No. |
JL20220811 |
|
Cas |
103060-53-3 |
MF Date |
Aug. 11, 2022 |
|
Packing |
1KG/BAG |
Analysis Date |
Aug. 11, 2022 |
|
Quantity |
100KGS |
Expiry Date |
Aug. 10, 2024 |
|
ITEM |
STANDARD |
RESULT |
|
|
Appearance |
Light yellow to yellow powder |
Conform |
|
|
Odor |
Odorless |
Conform |
|
|
Assay |
≥95.0% |
97.9% |
|
|
Specific optical rotation |
+15.5～+20.5 |
+16.8 |
|
|
Clarity ofsolution |
Clarified |
Clarified |
|
|
PH |
3.0～4.5 |
3.2 |
|
|
Residue on ignition |
≤0.2% |
0.1% |
|
|
Water |
≤5.0% |
2.4% |
|
|
Lactone hydrolysate |
≤0.80% |
0.08% |
|
|
β-isomer |
≤1.5% |
0.1% |
|
|
RS-5/6 |
≤0.80% |
0.06% |
|
|
RS-7 |
≤0.80% |
Not detected |
|
|
RS-7a/7b |
≤0.20% |
0.07% |
|
|
Anhydrodaptomycin |
≤2.0% |
0.8% |
|
|
Other individual |
≤0.15% |
Not detected |
|
|
Total impurities |
≤5.0% |
1.1% |
|
|
Ethyl alcohol |
≤0.5% |
0.0% |
|
|
Acetic acid |
≤0.5% |
Not detected |
|
|
Bacterial endotoxin(EU/mg) |
≤0.28 |
<0.28 |
|
|
Aerobic bacteria(cfu/g) |
≤1000 |
<10 |
|
|
Mold &yeast(cfu/g) |
≤100 |
<10 |
|
|
E.coil |
Not detected |
Not detected |
|
|
Conclusion |
Qualified |
||
Medical intermediate for the treatment of concurrent skin and skin structure infections caused by some gram-positive and sensitive strains.
1kgs bag or requirement of clients. Keep it away from light at a temperature below 25℃.
Daptomycin With Cas 103060-53-3
